Hoang Tung T, Sullivan Sarah A, Cusick John K, Schweizer Herbert P
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523-1682A, USA1.
Microbiology (Reading). 2002 Dec;148(Pt 12):3849-3856. doi: 10.1099/00221287-148-12-3849.
The two acyl-homoserine lactones (AHLs) N-(butyryl)-L-homoserine lactone and N-[3-oxododecanoyl]-L-homoserine lactone (3-oxo-C(12)-HSL) are required for quorum sensing in Pseudomonas aeruginosa. These AHLs derive their invariant lactone rings from S-adenosylmethionine and their variable acyl chains from the cellular acyl-acyl carrier protein (ACP) pool. This reaction is catalysed by specific AHL synthases, which exhibit acyl chain specificity. Culture supernatants of P. aeruginosa contain multiple 3-oxo-AHLs that differ in their acyl chain lengths but their physiological role, if any, remains unknown. An in vitro fatty acid-3-oxo-AHL synthesis system was established utilizing purified P. aeruginosa Fab proteins, ACP and the LasI 3-oxo-AHL synthase. In the presence of excess protein, substrates and cofactors, this system produced almost exclusively 3-oxo-C(12)-HSL. When the beta-ketoacyl-ACP reductase (FabG) catalysed step was made rate-limiting by switching from the preferred NADPH cofactor to NADH, increased levels of short chain 3-oxo-AHLs were produced, presumably because shorter-chain ketoacyl-ACPs accumulated and thus became LasI substrates. Consistent with these in vitro observations, a fabG(Ts) mutant produced increased amounts of 3-oxo-AHLs in vivo. Thus, in vitro and in vivo evidence indicated that modulation of FabG activity of the fatty acid biosynthetic pathway may determine the acyl chain lengths of these 3-oxo-AHLs and that the LasI 3-oxo-AHL synthase is sufficient for their synthesis.
两种酰基高丝氨酸内酯(AHLs),即N-(丁酰基)-L-高丝氨酸内酯和N-[3-氧代十二烷酰基]-L-高丝氨酸内酯(3-氧代-C(12)-HSL),是铜绿假单胞菌群体感应所必需的。这些AHLs的不变内酯环源自S-腺苷甲硫氨酸,其可变酰基链源自细胞酰基-酰基载体蛋白(ACP)库。该反应由具有酰基链特异性的特定AHL合成酶催化。铜绿假单胞菌的培养上清液含有多种酰基链长度不同的3-氧代-AHLs,但其生理作用(如果有)仍不清楚。利用纯化的铜绿假单胞菌Fab蛋白、ACP和LasI 3-氧代-AHL合成酶建立了体外脂肪酸-3-氧代-AHL合成系统。在存在过量蛋白质、底物和辅因子的情况下,该系统几乎只产生3-氧代-C(12)-HSL。当通过从首选的NADPH辅因子转换为NADH使β-酮酰基-ACP还原酶(FabG)催化步骤成为限速步骤时,短链3-氧代-AHLs的产量增加,推测是因为较短链的酮酰基-ACPs积累并因此成为LasI的底物。与这些体外观察结果一致,fabG(Ts)突变体在体内产生了更多量的3-氧代-AHLs。因此,体外和体内证据表明,脂肪酸生物合成途径中FabG活性的调节可能决定这些3-氧代-AHLs的酰基链长度,并且LasI 3-氧代-AHL合成酶足以合成它们。